COV up +3.13% percent Today $COV High is at 98.32 and the Low 94.66 with current volume of 1,549,868.
Recent News posted below.
Covidien Plc. COV other info.
http://investorshangout.com/Covidien-Plc-COV-50596/
COV Covidien Plc. Recent Headline News
InsiderInsights.com Daily Round Up 11/17/14: SFM, INTX, GNRC, GSAT
InsiderInsights - at Seeking Alpha - Tue Nov 18, 5:55AM CST
HCOM: 26.98 (-0.03), IPHI: 14.20 (+0.58), JBHT: 80.00 (+0.24), COV: 97.76 (+3.15), OPHT: 40.19 (+0.04), COP: 71.23 (-0.19), SFM: 31.22 (+0.31), GOOG: 539.30 (+2.79), GSAT: 2.60 (-0.20), STAY: 18.54 (-0.02), ZOES: 32.98 (-0.20), INTX: 3.81 (+0.07), GNRC: 43.27 (+1.39), HZNP: 12.75 (+0.25), TRUE: 17.80 (+0.20)
Covidien's Test Data Positive for VenaSeal Closure System - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 17, 5:10PM CST
Covidien plc (COV) recently announced six-month results from the VeClose pivotal study, which was carried out to evaluate the safety and efficiency of the VenaSeal closure system, a treatment option for chronic venous disorders.
JNJ: 109.03 (+0.73), BDX: 130.31 (+0.77), BCR: 166.90 (+2.09), COV: 97.76 (+3.15)
Medtronic and Covidien Shareholder Meetings Scheduled for January 6, 2015
Thomson Reuters ONE - Mon Nov 17, 11:30AM CST
MDT: 71.83 (+2.64), COV: 97.76 (+3.15)
Six Month Results of VeClose Study Demonstrate Safety, Effectiveness of the VenaSeal(TM) Closure System
Business Wire - Thu Nov 13, 5:00PM CST
Covidien plc (NYSE:COV) today announced the six-month results of the VeClose pivotal study, which demonstrated the safety and effectiveness of the VenaSeal(TM) closure system* in patients with chronic venous insufficiency (CVI) having symptomatic reflux in the great saphenous vein. The results were presented at American College of Phlebology Annual Congress (ACP 2014) in Phoenix, Ariz.
COV: 97.76 (+3.15)
Form 8.1 - Covidien
Business Wire - Thu Nov 13, 10:17AM CST
Covidien plc:
COV: 97.76 (+3.15)
Insider Trading Alert - CTSH, PSEC And COV Traded By Insiders
at The Street - Thu Nov 13, 9:15AM CST
Stocks with insider trader activity include CTSH, PSEC and COV
COV: 97.76 (+3.15), CTSH: 52.83 (-0.23), PSEC: 9.64 (-0.02)
Covidien Shares Up 28.9% Since SmarTrend's Buy Recommendation (COV)
Comtex SmarTrend(R) - Wed Nov 12, 9:16AM CST
SmarTrend identified an Uptrend for Covidien (NYSE:COV) on May 12th, 2014 at $72.16. In approximately 6 months, Covidien has returned 28.91% as of today's recent price of $93.02.
COV: 97.76 (+3.15)
Wall Street Breakfast: Global Banks Fined $3.4B In Forex Probe
Wall Street Breakfast - Seeking Alpha - Wed Nov 12, 5:30AM CST
Economy Japanese stocks scaled seven-year highs this morning on further speculation that Prime Minister Shinzo Abe will postpone a planned sales tax hike and call a general election for December. The Sankei newspaper reported that Abe would...
VRX: 141.28 (+4.55), MDT: 71.82 (+2.63), C: 54.06 (+0.49), WMT: 83.91 (+0.34), RBS: 11.99 (+0.07), UBS: 17.50 (+0.05), NOK: 7.98 (+0.31), YHOO: 51.58 (-0.79), PBR: 8.90 (-0.43), SPY: 205.23 (+0.86), SAP: 68.48 (+0.96), EBAY: 55.01 (+0.18), JPM: 60.72 (+0.34), BHP: 57.35 (-0.84), AAPL: 114.43 (+0.44), BCS: 14.89 (+0.19), FRM: 6.33 (+0.21), COV: 97.76 (+3.15), HSBC: 50.00 (-0.05), FRGI: 56.56 (+0.90), ZTS: 43.85 (-0.38), DLA: 10.62 (+0.10), QQQ: 103.49 (+0.58), AOL: 46.19 (-0.52), BABA: 111.19 (-3.06)
Medtronic submits concessions for $43B Covidien takeover
Seeking Alpha - at Seeking Alpha - Wed Nov 12, 3:53AM CST
MDT: 71.82 (+2.63), COV: 97.76 (+3.15)
Insider Trading Alert - TSLA, COV And AKS Traded By Insiders
at The Street - Tue Nov 11, 9:08AM CST
Stocks with insider trader activity include TSLA, COV and AKS
TSLA: 258.13 (+4.15), COV: 97.76 (+3.15), AKS: 6.41 (-0.03)
Covidien Set to Possibly Pullback After Yesterday's Rally of 1.69%
Comtex SmarTrend(R) - Mon Nov 10, 3:57PM CST
Covidien (NYSE:COV) traded in a range yesterday that spanned from a low of $92.19 to a high of $93.74. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of $93.68 on volume of 3.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
COV: 97.76 (+3.15)
Watch for Covidien to Potentially Pullback After Gaining 1.69% Yesterday
Comtex SmarTrend(R) - Mon Nov 10, 3:57PM CST
Covidien (NYSE:COV) traded in a range yesterday that spanned from a low of $92.19 to a high of $93.74. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of $93.68 on volume of 3.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
COV: 97.76 (+3.15)
Quarterly Financial Results, Study Results, and Appointments - Research Reports on Covidien, Community Health, Express Scripts, Caterpillar and Boeing
PR Newswire - Fri Nov 07, 7:35AM CST
Today, Analysts Review released its research reports regarding Covidien plc (NYSE: COV), Community Health Systems, Inc. (NYSE: CYH), Express Scripts Holding Company (NASDAQ: ESRX), Caterpillar Inc. (NYSE: CAT) and The Boeing Company (NYSE: BA). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7772-100free.
ESRX: 79.46 (+0.40), CYH: 48.51 (+2.01), COV: 97.76 (+3.15), CAT: 101.51 (-0.19), BA: 129.87 (+1.45)
Top 2 MedTech Stocks, Poised to Gain on Earnings this Season - Earnings ESP
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 9:36AM CST
Medical device is one of such sectors which are projected to be highly affected by the midterm election results.
DSCI: 8.51 (+0.11), MDT: 71.82 (+2.63), UNIS: 2.89 (+0.06), COV: 97.76 (+3.15), SHPG: 209.00 (+3.01), ABBV: 65.78 (+0.74), WAG: 67.40 (+0.85)
Company News for November 06, 2014 - Corporate Summary
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 9:10AM CST
Companies in the News are: ACT,CTSH,COV,TW
ACT: 260.34 (+12.40), COV: 97.77 (+3.16), CTSH: 52.83 (-0.23), TW: 113.87 (+0.85)
SmarTrend Watching for Potential Pullback in Shares of Covidien After 1.36% Gain
Comtex SmarTrend(R) - Wed Nov 05, 4:08PM CST
Covidien (NYSE:COV) traded in a range yesterday that spanned from a low of $92.69 to a high of $93.68. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $92.89 on volume of 3.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
COV: 97.77 (+3.16)
Covidien Announces Nine-Month Results of DURABILITY Iliac Study, Addition of Iliac Indication for EverFlex(TM) Stent System at VIVA 2014
Business Wire - Wed Nov 05, 3:06PM CST
Covidien plc (NYSE: COV) today announced nine-month results of the DURABILITY Iliac study and addition of the iliac indication for its EverFlex(TM) stent at the Vascular Interventional Advances (VIVA) 2014 conference. The nine-month results confirm the safety and effectiveness of the EverFlex(TM) and Protege(TM) GPS(TM) self-expanding stent systems* for the treatment of lesions of the common and external iliac arteries.
COV: 97.77 (+3.16)
Covidien (COV) Beats on Q4 Earnings, Sales; Both Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 1:50PM CST
Covidien plc (COV) reported fourth-quarter fiscal 2014 earnings of $1.15 per share, which beat the Zacks Consensus Estimate by 14 cents.
MDT: 71.82 (+2.63), GWPH: 79.17 (+2.61), ABAX: 54.99 (+0.33), COV: 97.77 (+3.16)
Recent News posted below.
Covidien Plc. COV other info.
http://investorshangout.com/Covidien-Plc-COV-50596/
COV Covidien Plc. Recent Headline News
InsiderInsights.com Daily Round Up 11/17/14: SFM, INTX, GNRC, GSAT
InsiderInsights - at Seeking Alpha - Tue Nov 18, 5:55AM CST
HCOM: 26.98 (-0.03), IPHI: 14.20 (+0.58), JBHT: 80.00 (+0.24), COV: 97.76 (+3.15), OPHT: 40.19 (+0.04), COP: 71.23 (-0.19), SFM: 31.22 (+0.31), GOOG: 539.30 (+2.79), GSAT: 2.60 (-0.20), STAY: 18.54 (-0.02), ZOES: 32.98 (-0.20), INTX: 3.81 (+0.07), GNRC: 43.27 (+1.39), HZNP: 12.75 (+0.25), TRUE: 17.80 (+0.20)
Covidien's Test Data Positive for VenaSeal Closure System - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 17, 5:10PM CST
Covidien plc (COV) recently announced six-month results from the VeClose pivotal study, which was carried out to evaluate the safety and efficiency of the VenaSeal closure system, a treatment option for chronic venous disorders.
JNJ: 109.03 (+0.73), BDX: 130.31 (+0.77), BCR: 166.90 (+2.09), COV: 97.76 (+3.15)
Medtronic and Covidien Shareholder Meetings Scheduled for January 6, 2015
Thomson Reuters ONE - Mon Nov 17, 11:30AM CST
MDT: 71.83 (+2.64), COV: 97.76 (+3.15)
Six Month Results of VeClose Study Demonstrate Safety, Effectiveness of the VenaSeal(TM) Closure System
Business Wire - Thu Nov 13, 5:00PM CST
Covidien plc (NYSE:COV) today announced the six-month results of the VeClose pivotal study, which demonstrated the safety and effectiveness of the VenaSeal(TM) closure system* in patients with chronic venous insufficiency (CVI) having symptomatic reflux in the great saphenous vein. The results were presented at American College of Phlebology Annual Congress (ACP 2014) in Phoenix, Ariz.
COV: 97.76 (+3.15)
Form 8.1 - Covidien
Business Wire - Thu Nov 13, 10:17AM CST
Covidien plc:
COV: 97.76 (+3.15)
Insider Trading Alert - CTSH, PSEC And COV Traded By Insiders
at The Street - Thu Nov 13, 9:15AM CST
Stocks with insider trader activity include CTSH, PSEC and COV
COV: 97.76 (+3.15), CTSH: 52.83 (-0.23), PSEC: 9.64 (-0.02)
Covidien Shares Up 28.9% Since SmarTrend's Buy Recommendation (COV)
Comtex SmarTrend(R) - Wed Nov 12, 9:16AM CST
SmarTrend identified an Uptrend for Covidien (NYSE:COV) on May 12th, 2014 at $72.16. In approximately 6 months, Covidien has returned 28.91% as of today's recent price of $93.02.
COV: 97.76 (+3.15)
Wall Street Breakfast: Global Banks Fined $3.4B In Forex Probe
Wall Street Breakfast - Seeking Alpha - Wed Nov 12, 5:30AM CST
Economy Japanese stocks scaled seven-year highs this morning on further speculation that Prime Minister Shinzo Abe will postpone a planned sales tax hike and call a general election for December. The Sankei newspaper reported that Abe would...
VRX: 141.28 (+4.55), MDT: 71.82 (+2.63), C: 54.06 (+0.49), WMT: 83.91 (+0.34), RBS: 11.99 (+0.07), UBS: 17.50 (+0.05), NOK: 7.98 (+0.31), YHOO: 51.58 (-0.79), PBR: 8.90 (-0.43), SPY: 205.23 (+0.86), SAP: 68.48 (+0.96), EBAY: 55.01 (+0.18), JPM: 60.72 (+0.34), BHP: 57.35 (-0.84), AAPL: 114.43 (+0.44), BCS: 14.89 (+0.19), FRM: 6.33 (+0.21), COV: 97.76 (+3.15), HSBC: 50.00 (-0.05), FRGI: 56.56 (+0.90), ZTS: 43.85 (-0.38), DLA: 10.62 (+0.10), QQQ: 103.49 (+0.58), AOL: 46.19 (-0.52), BABA: 111.19 (-3.06)
Medtronic submits concessions for $43B Covidien takeover
Seeking Alpha - at Seeking Alpha - Wed Nov 12, 3:53AM CST
MDT: 71.82 (+2.63), COV: 97.76 (+3.15)
Insider Trading Alert - TSLA, COV And AKS Traded By Insiders
at The Street - Tue Nov 11, 9:08AM CST
Stocks with insider trader activity include TSLA, COV and AKS
TSLA: 258.13 (+4.15), COV: 97.76 (+3.15), AKS: 6.41 (-0.03)
Covidien Set to Possibly Pullback After Yesterday's Rally of 1.69%
Comtex SmarTrend(R) - Mon Nov 10, 3:57PM CST
Covidien (NYSE:COV) traded in a range yesterday that spanned from a low of $92.19 to a high of $93.74. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of $93.68 on volume of 3.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
COV: 97.76 (+3.15)
Watch for Covidien to Potentially Pullback After Gaining 1.69% Yesterday
Comtex SmarTrend(R) - Mon Nov 10, 3:57PM CST
Covidien (NYSE:COV) traded in a range yesterday that spanned from a low of $92.19 to a high of $93.74. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of $93.68 on volume of 3.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
COV: 97.76 (+3.15)
Quarterly Financial Results, Study Results, and Appointments - Research Reports on Covidien, Community Health, Express Scripts, Caterpillar and Boeing
PR Newswire - Fri Nov 07, 7:35AM CST
Today, Analysts Review released its research reports regarding Covidien plc (NYSE: COV), Community Health Systems, Inc. (NYSE: CYH), Express Scripts Holding Company (NASDAQ: ESRX), Caterpillar Inc. (NYSE: CAT) and The Boeing Company (NYSE: BA). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7772-100free.
ESRX: 79.46 (+0.40), CYH: 48.51 (+2.01), COV: 97.76 (+3.15), CAT: 101.51 (-0.19), BA: 129.87 (+1.45)
Top 2 MedTech Stocks, Poised to Gain on Earnings this Season - Earnings ESP
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 9:36AM CST
Medical device is one of such sectors which are projected to be highly affected by the midterm election results.
DSCI: 8.51 (+0.11), MDT: 71.82 (+2.63), UNIS: 2.89 (+0.06), COV: 97.76 (+3.15), SHPG: 209.00 (+3.01), ABBV: 65.78 (+0.74), WAG: 67.40 (+0.85)
Company News for November 06, 2014 - Corporate Summary
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 9:10AM CST
Companies in the News are: ACT,CTSH,COV,TW
ACT: 260.34 (+12.40), COV: 97.77 (+3.16), CTSH: 52.83 (-0.23), TW: 113.87 (+0.85)
SmarTrend Watching for Potential Pullback in Shares of Covidien After 1.36% Gain
Comtex SmarTrend(R) - Wed Nov 05, 4:08PM CST
Covidien (NYSE:COV) traded in a range yesterday that spanned from a low of $92.69 to a high of $93.68. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $92.89 on volume of 3.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
COV: 97.77 (+3.16)
Covidien Announces Nine-Month Results of DURABILITY Iliac Study, Addition of Iliac Indication for EverFlex(TM) Stent System at VIVA 2014
Business Wire - Wed Nov 05, 3:06PM CST
Covidien plc (NYSE: COV) today announced nine-month results of the DURABILITY Iliac study and addition of the iliac indication for its EverFlex(TM) stent at the Vascular Interventional Advances (VIVA) 2014 conference. The nine-month results confirm the safety and effectiveness of the EverFlex(TM) and Protege(TM) GPS(TM) self-expanding stent systems* for the treatment of lesions of the common and external iliac arteries.
COV: 97.77 (+3.16)
Covidien (COV) Beats on Q4 Earnings, Sales; Both Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 1:50PM CST
Covidien plc (COV) reported fourth-quarter fiscal 2014 earnings of $1.15 per share, which beat the Zacks Consensus Estimate by 14 cents.
MDT: 71.82 (+2.63), GWPH: 79.17 (+2.61), ABAX: 54.99 (+0.33), COV: 97.77 (+3.16)
